Bettina M. Cockroft's most recent trade in Annexon Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annexon Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Cns Pharmaceuticals Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 35,574 | - | - | Option to purchase common stock | |
| Cns Pharmaceuticals Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 53,074 | - | - | Restricted Stock Units | |
| Annexon Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Cns Pharmaceuticals Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 2,099 | 2,099 | - | - | Option to purchase common stock | |
| Annexon Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | Bettina M. Cockroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |